Anti-Human CD299/CLEC4M Recombinant Antibody (16E7#) (HV022107)

Name: Anti-Human CD299/CLEC4M Recombinant Antibody (16E7#)
Brand: abinScience
SKU: HV022107
Price: 191 USD
Availability: InStock

Prix(USD) :

Spécification :

Nombre :

Contactez-nous

Aperçu

Numéro de catalogue	HV022107
Reactivité des espèces	Human
Applications	FCM
Espèce hôte	Mouse
Clonalité	Monoclonal
Isotype	IgG1, kappa
ID de clone	16E7#
Cible	DC-SIGNR, DC-SIGN2, CLEC4M, DC-SIGN-related protein, C-type lectin domain family 4 member M, CD299, L-SIGN, CD209L, Liver/lymph node-specific ICAM-3-grabbing non-integrin, CD209L1, Dendritic cell-specific ICAM-3-grabbing non-integrin 2, CD209 antigen-like protein 1
Niveau d'endotoxines	Please contact with the lab for this information.
Pureté	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Numéro d'accès	Q9H2X3
Forme	Liquid
Tampon de stockage	0.01M PBS pH 7.4 Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.
Stabilité et stockage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Contexte	C-type lectin domain family 4 member M (CD299/CLEC4M) is a ~45 kDa protein. Probable pathogen-recognition receptor involved in peripheral immune surveillance in liver. May mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments. Is a receptor for ICAM3, probably by binding to mannose-like carbohydrates.
Note	For research use only.

Images

Reférences

Fiche technique

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Aperçu